Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01153529 · ClinicalTrials.gov registry record

Post-Deployment Afghanistan/Iraq Trauma Related Inventory of Traits (PATRIOT): Phase 1 (Feasibility Study)

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
250
Enrollment target

NCT01153529 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 250 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01153529 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
250 participants
Enrollment target

Study Summary

The long-term goal of this research project is to identify genes that contribute to or guard against developing posttraumatic stress disorder (PTSD) and to better understand how genes and life experiences work together to impact PTSD. Inherited traits are passed down from one generation to the next in genes. Genes contain molecules called DNA, which contain the information that determines our characteristics and carries instructions for constructing and operating our body. Most human diseases have an inherited element. In addition, we, the investigators, hope to learn about how genes and the other materials we find in participants' blood relate to other illnesses and behaviors. The goal of the feasibility project covered by this application is to test the possibility of conducting research on a large number of veterans in order to look at the association between genes and PTSD. We are inviting 1,000 OEF/OIF veterans to participate, of these, we are anticipating approximately 250 veterans who have served in Afghanistan and/or Iraq to participate in this study. Although 250 participants is our target enrollment, we plan to enroll all veterans included in our initial mailings who desire to participate. We do not anticipate this to exceed 500 individuals. This phase of the study is expected to last about one year. Specific aims are: 1. evaluation of sampling methods and participation rates; 2. field testing of assessment batteries including reliability and validity; and 3. evaluation of the proposed DNA collection and storage procedures.

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2011-09
Est. Completion 2012-09

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT01153529

The ClinicalTrials.gov registry entry for NCT01153529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01153529 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01153529 about?

NCT01153529 is a clinical study titled "Post-Deployment Afghanistan/Iraq Trauma Related Inventory of Traits (PATRIOT): Phase 1 (Feasibility Study)". The long-term goal of this research project is to identify genes that contribute to or guard against developing posttraumatic stress disorder (PTSD) and to better understand how genes and life experiences work together to impact PTSD. Inherited traits are passed down from one generation to the next ...

What is the current status of trial NCT01153529?

This trial is currently completed. The enrollment target is 250 participants. The study started on 2011-09. Estimated completion is 2012-09.

Who is sponsoring clinical trial NCT01153529?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.